Delivered as a comprehensive Software-As-A-Service (SaaS) solution, the LabVantage COVID-19 Biobanking Accelerator requires no infrastructure investment.
NanoString Technologies has announced the launch of nCounter Human Organ Transplant, a gene expression panel for researchers to evaluate the human immune response following organ transplantation.
Oncology Analytics announced the release of Oncology Insights, a next-generation analytics software solution that delivers current, relevant, and structured oncology data, supported by expert...
PerkinElmer has introduced the PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing for Aneuploidy (PGT-A) kit, that tests spent embryo culture media for chromosomal abnormalities during in vitro fertilization (IVF) treatment.
Each of the new panels comes with ERASE-Seq, Fluxion's variant caller which uses statistical analysis to compare sequencing results across several molecular amplification pools.
The kit is designed for purification of circulating cfNDA and uses silica coated paramagnetic particles to purify cfDNA from less than 1 mL to greater than 10 mL of serum or plasma.
EsoGuard is designed to facilitate the diagnosis of Barrett’s Esophagus (BE) and related precursors to highly lethal esophageal adenocarcinoma (EAC).
The PD-L1 assay and the AccuCyte-CyteFinder system processes a single tube of blood to cells for CTC enumeration and PD-L1 biomarker expression analysis, and to plasma for optional cfDNA analysis.
Liquid biopsy test provider Biocept has announced Target Selector NGS Breast Panel, a multi-gene liquid biopsy panel specifically developed for breast cancer. The Target...
Cancer diagnostics company Genecast has launched of ADPS BRAF, EGFR, JAK2 mutation test kits with the highest detection sensitivity. Currently available for research use...